Quetiapine modified-release versus immediate-release in early psychosis

被引：0
|
作者：
Kelbrick, Marlene [1 ]
机构：
[1] Northamptonshire Healthcare NHS Fdn Trust, Early Intervent Psychosis, Kettering, England
来源：
PROGRESS IN NEUROLOGY AND PSYCHIATRY | 2019年 / 23卷 / 04期
关键词：
REPORTED SEDATION PROFILE; 1ST-EPISODE PSYCHOSIS; EXTENDED-RELEASE; DOUBLE-BLIND; ANTIPSYCHOTIC MEDICATION; BIPOLAR DEPRESSION; SCHIZOPHRENIA; MANAGEMENT; EFFICACY; NONADHERENCE;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Antipsychotic treatment choice in first-episode psychosis is multifaceted with a need to focus on all aspects of recovery. There are clear differences between quetiapine immediaterelease (IR) and modified-release (MR) that may have clinical significance in this patient group.
引用
收藏
页码：29 / 31
页数：3
相关论文
共 50 条
  • [21] Influence of Various Media on the Dissolution Profiles of Immediate-Release Quetiapine Tablets in India
    Shah, Zubin
    Londhe, Vaishali
    DISSOLUTION TECHNOLOGIES, 2016, 23 (01): : 42 - 46
  • [22] POPULATION PK MODELING OF IMMEDIATE-RELEASE PHENTERMINE AND MODIFIED-RELEASE TOPIRAMATE ADMINISTERED AS A FIXED-DOSE COMBINATION PRODUCT (VI-0521).
    Marier, J. F.
    Kassir, N.
    Mouksassi, M. S.
    Gosselin, N. H.
    Yee, S.
    Peterson, C.
    Day, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S123 - S123
  • [23] Comparative pharmacokinetics of two modified-release oral morphine formulations (Reliadol® and Kapanol®) and an immediate-release morphine tablet (Morfin 'DAK') in healthy volunteers
    Bochner, F
    Somogyi, AA
    Christrup, LL
    Larsen, U
    Danz, C
    Elbaek, K
    CLINICAL DRUG INVESTIGATION, 1999, 17 (01) : 59 - 66
  • [24] Risks and benefits of oral modified-release compared with oral immediate-release opioid use after surgery: a systematic review and meta-analysis
    Liu, S.
    Athar, A.
    Quach, D.
    Patanwala, A. E.
    Naylor, J. M.
    Stevens, J. A.
    Levy, N.
    Knaggs, R. D.
    Lobo, D. N.
    Penm, J.
    ANAESTHESIA, 2023, 78 (10) : 1225 - 1236
  • [25] Comparative Pharmacokinetics of Two Modified-Release Oral Morphine Formulations (Reliadol® and Kapanol®) and an Immediate-Release Morphine Tablet (Morfin ‘DAK’) in Healthy Volunteers
    F. Bochner
    A. A. Somogyi
    L. L. Christrup
    U. Larsen
    C. Danz
    K. Elbæk
    Clinical Drug Investigation, 1999, 17 : 59 - 66
  • [26] Safety of Immediate-Release Nifedipine
    Means, Laura
    Benken, Scott T.
    Tesoro, Eljim P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 68 (05) : 395 - 399
  • [27] A case for immediate-release niacin
    Bassan, Mayer
    HEART & LUNG, 2012, 41 (01): : 95 - 98
  • [28] Modified-release tacrolimus
    Chisholm, MA
    Middleton, MD
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (02) : 270 - 275
  • [29] CIRCULATING IL-6 AND OTHER METABOLIC BIOMARKERS COMPARING EFFECTS OF MODIFIED-RELEASE PREDNISONE (MR) AND IMMEDIATE-RELEASE PREDNISOLONE (IR) IN NEW GCA
    Miler, E.
    Mapplebeck, S.
    Mackerness, C.
    Wilson, L.
    Aung, T.
    Gayford, D.
    Schofield, J. P.
    Dasgupta, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 609 - 609
  • [30] Modified-release versus standard prednisone in rheumatoid arthritis
    Buttgereit, Frank
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) : 182 - 182
12345